Silmitasertib (CX-4945) Disrupts ERα/HSP90 Interaction and Drives Proteolysis through the Disruption of CK2β Function in Breast Cancer Cells

Hogyoung Kim(Tulane University), Christopher Kwesi O. Williams(Xavier University of Louisiana)
Cancers
July 10, 2024
Cited by 2


Related Papers